VIR BIOTECHNOLOGY INC's ticker is and the CUSIP is 92764N952. A total of 4 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $856,418 | -37.7% | 91,400 | +63.2% | 0.00% | -25.0% |
| Q2 2023 | $1,373,680 | +19577.4% | 56,000 | +18566.7% | 0.00% | – |
| Q1 2023 | $6,981 | -94.7% | 300 | -94.2% | 0.00% | – |
| Q4 2022 | $131,612 | +186.1% | 5,200 | +116.7% | 0.00% | – |
| Q3 2022 | $46,000 | -67.8% | 2,400 | -57.1% | 0.00% | – |
| Q2 2022 | $143,000 | -43.3% | 5,600 | -42.9% | 0.00% | – |
| Q1 2022 | $252,000 | -79.1% | 9,800 | -66.0% | 0.00% | -100.0% |
| Q4 2021 | $1,206,000 | -10.0% | 28,800 | -6.5% | 0.00% | 0.0% |
| Q3 2021 | $1,340,000 | -19.3% | 30,800 | -12.3% | 0.00% | -50.0% |
| Q2 2021 | $1,660,000 | -50.0% | 35,100 | -45.8% | 0.00% | -60.0% |
| Q1 2021 | $3,322,000 | +367.9% | 64,800 | +144.5% | 0.01% | +400.0% |
| Q4 2020 | $710,000 | +60.3% | 26,500 | +105.4% | 0.00% | 0.0% |
| Q3 2020 | $443,000 | -28.9% | 12,900 | -15.1% | 0.00% | -66.7% |
| Q2 2020 | $623,000 | – | 15,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 91,400 | $856,418 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| SIMPLEX TRADING, LLC | 4,400 | $41 | 0.00% |
| JPMORGAN CHASE & CO | 30,000 | $281,100 | 0.00% |